Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Weight management refers broadly to the physiological processes that regulate body mass through balancing energy intake and expenditure. It encompasses numerous biological systems including appetite control in the hypothalamus, adipose tissue metabolism, digestive enzyme activity, hormonal signaling such as leptin/insulin/GLP1/GIPR axes, and genetic factors influencing fat storage and utilization. Therapeutic strategies for obesity often focus on modulating these underlying mechanisms using pharmacological agents that act on defined targets like GLP1 receptors or GIP receptors in order to reduce food intake or increase energy expenditure. However, "weight management" itself is not a discrete molecule or receptor but represents an aggregate outcome resulting from complex interactions among many biological targets.
Mechanisms are diverse and depend on the actual molecular target. Examples include: Appetite suppression via central nervous system pathways (GLP1R agonists); Increased energy expenditure via adipocyte signaling (GIPR modulation); Inhibition of fat absorption in the gut (lipase inhibitors).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Weight Management.